KMG Chemicals (NYSE: KMG) reported Q3 EPS of $1.10, $0.26 better than the analyst estimate of $0.84. Revenue for the quarter came in at $118.6 million versus the consensus estimate of $112.97 million.

Fiscal 2018 Outlook

• Sales: We increase our fiscal 2018 consolidated net sales forecast to $455-465 million, from our prior guidance of $445-455 million.
• Adjusted EBITDA: We increase our adjusted EBITDA forecast to $118-120 million, from our prior guidance of $114-118 million, reflecting stronger growth expectations in both our electronic chemicals and performance materials segments. Our revised fiscal 2018 adjusted EBITDA forecast includes approximately $8.0 million in stock-based compensation expense, unchanged from our prior estimate.
• Depreciation and Amortization: Depreciation and amortization expense is forecast to be approximately $30 million.
• Capital Expenditures: Capital expenditures are forecast to be approximately $25 million, down from our prior estimate of approximately $29 million.

(Street sees FY revenue of $455.3M)

For earnings history and earnings-related data on KMG Chemicals (KMG) click here.